RESUMEN
BACKGROUND: Melanoma is a skin cancer that has higher mortality among cutaneous malignant tumours. Tumour incidence in most world regions is rising. Here, we intend to highlight these trends in the world. METHODS: We used the global burden of disease dataset to assess the incidence and mortality of melanoma from 1995 to 2019 in 204 countries/territories. To identify country/territory groups with similar trends of melanoma incidence and mortality, a model-based clustering with a mixture of multivariate t-distributions was used. RESULTS: Australia and New Zealand had the largest incidence and mortality rates. Men in Egypt and women in Sri Lanka and Guam had the lowest incidence and mortality rates. The clustering analysis revealed 4 classes of incidence in both gender and 3 and 2 classes of mortality in male and female, respectively. All groups had a growing incidence rate in both gender, similar to the worldwide trend. In 10% of the countries/territories, central and Western Europe, the incidence increase rate was greater than in the countries/territories with the greatest incidence. The total mortality rate for men was steadily growing, although it was decreasing in Asian and African countries/territories. Overall, the mortality rate for women remained relatively steady over time. CONCLUSION: Due to the increasing trend of melanoma in the world, primary and secondary prevention of this disease, especially in areas with higher incidence and mortality, is essential. Raising awareness about the disease is helpful in prevention and early detection of melanoma.
Asunto(s)
Melanoma , Neoplasias Cutáneas , Análisis por Conglomerados , Europa (Continente)/epidemiología , Femenino , Humanos , Incidencia , Masculino , Melanoma/patología , Neoplasias Cutáneas/patologíaRESUMEN
Methamphetamine (METH) is a strong psychostimulant drug which can essentially affect different brain regions. Hippocampus as one of main components of limbic system plays key roles in processing of short term, long term and spatial memory. Herein, we explored the changes in behavior, synaptic transmission and hippocampal volume along with gliosis following METH treatment. Besides, using genome-wide expression profiling, we applied a pathway-based approach to detect significantly dysregulated signaling pathways. In this regard, we found that METH administration interrupts spatial memory and long term potentiation (LTP). Additionally, stereological analysis revealed a significant alteration in hippocampal volume along with increased gliosis upon METH treatment. We also identified several signaling cascades chiefly related to synaptic transmission which were considerably interrupted in the hippocampus of METH-treated rats. Taken together, our data suggests a potential link between behavioral disruptions and dysregulated signaling pathways.
Asunto(s)
Estimulantes del Sistema Nervioso Central/farmacología , Gliosis/inducido químicamente , Hipocampo/efectos de los fármacos , Potenciación a Largo Plazo/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Metanfetamina/farmacología , Transducción de Señal/efectos de los fármacos , Memoria Espacial/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Estimulantes del Sistema Nervioso Central/administración & dosificación , Modelos Animales de Enfermedad , Hipocampo/patología , Masculino , Metanfetamina/administración & dosificación , Ratas , Ratas Sprague-Dawley , Transmisión Sináptica/efectos de los fármacosRESUMEN
A 70 year old man is presented with four distinct skin diseases that were diagnosed concomitantly. Lichen planus, vitiligo, lichen sclerosis, and disseminated actinic porokeratosis were all diagnosed clinically and histologically in this man, who was otherwise healthy.